In focus · trending topic

Immuron Limited

8 stories · following the connections

Immuron CEO to Present at RedChip Global Online Growth Conference

By Nasdaq OMXApr 23, 2018, 10:57 PM UTC

Immuron’s Travelan® Sales Continue to Soar in Third Quarter of FY2018 in Australian & US Markets

By Nasdaq OMXApr 23, 2018, 1:30 PM UTC

Immuron Announces A$5.1M Private Placement to U.S. Fund

By Nasdaq OMXMar 13, 2018, 10:20 PM UTC

Immuron Progresses Discussions with Institutional Funds

By Nasdaq OMXMar 13, 2018, 1:30 PM UTC

Immuron Reports Positive Results in NASH Clinical Trial

By Nasdaq OMXMar 7, 2018, 11:30 PM UTC

Immuron Limited Issues Correction to Misleading Halt Announcement Headline

By Nasdaq OMXMar 7, 2018, 10:06 PM UTC

Immuron to Receive $2.16M R&D Tax Concession Refund

By Nasdaq OMXJan 24, 2018, 2:30 PM UTC

Immuron Granted US Patent for NASH Treatment

By Nasdaq OMXNov 15, 2017, 2:00 PM UTC